Clinical trials recruiting in Rajkot, India
7
Recruiting trials
9
Conditions
Phase breakdown
Phase 2 4Phase 3 4
Conditions recruiting in Rajkot, India
Recruiting trials in Rajkot, India
- A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Assess the Efficacy and Safety of Induction and Maintenance Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
- A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
- LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder
Common questions
How many clinical trials are recruiting in Rajkot, India?
7 recruiting trials have at least one study site in Rajkot, India.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.